* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Bacterial Antistest
Cancer immunotherapy wikipedia , lookup
Hepatitis B wikipedia , lookup
Autoimmune encephalitis wikipedia , lookup
Polyclonal B cell response wikipedia , lookup
Diagnosis of HIV/AIDS wikipedia , lookup
Infection control wikipedia , lookup
Immunocontraception wikipedia , lookup
Anti-nuclear antibody wikipedia , lookup
IVD BACTERIAL ANTIGENS Store at 2 - 8ºC. vial dropper 5 ml Bacterial Antigens Slide and tube agglutination Bacterial antigens C. Tube test CLINICAL SIGNIFICANE Febrile diseases diagnostic may be assessed either by microorganism isolation or by titration of specific antibodies, somatic (O) and flagellar (H). The detection of these antibodies forms the basis for the long established Widal test. This test dedicates that a serum with high levels of agglutinating antibodies to O and H >1/100 is indicative of the infection with these microorganism. PRINCIPLE OF THE METHOD The Bacterial Antigens is a slide and tube agglutination test for the qualitative and semi-quantitative detection of antibodies anti-Salmonella, Brucella and certain Rickettsias in human serum. The reagents are standardized suspensions of killed and stained bacteria. When the antibodies are present in serum, a clear agglutination becomes evident. REAGENTS Code Reagent 5011 5021 5031 5041 5051 5061 5071 5081 5091 5092 5101 5111 5121 5901 5902 Antigen Salmonella paratyphi A H a flagelar Salmonella paratyphi A O 1, 2, 12 somatico Salmonella paratyphi B H b flagelar Salmonella paratyphi B O 1, 4, 5, 12 somatico Salmonella paratyphi C H c flagelar Salmonella paratyphi C O 6, 7 somatico Salmonella Typhi H d flagelar Salmonella Typhi O 1, 9, 12 somatico Brucella abortus* somatico Brucella melitensis somatico Proteus OX2 (P. vulgaris) somatico Proteus OX19 (P. vulgaris) somatico Proteus OXK (P. mirabilis) somatico Polyvalent positive control 1 ml Polyvalent negative control 2,5 ml 1. Prepare a row of test tubes for each disposition : Dilution 1/20 1/40 1/80 sample 100 µl saline 1,9 ml 1 ml 1 ml 1 ml 1 ml antigen according with the following 1/160 … 1 ml 1 ml 1 ml 1 ml Discard 1 ml 2. Prepare 2 tubes for Positive and Negative control: 0,1 mL Control + 0,9 mL NaCl 9 g/L (saline). 3. Add to each tube a drop (50 µl) of antigen suspension, previously shaken. 4. Mix thoroughly and incubate tube test at 37°C for 24 hours. The incubation period may be accelerated as follows: - For somatic (O) and Proteus antigens : 4 hours at 48-50°C. - For flagelar (H) antigens : 2 hours at 48-50°C. READING AND INTERPRETATION A single positive result has less significance than the demonstration of a rising or falling antibodies titer as evidence of infection. A clinical diagnosis should not be made on findings of a single test result, but should integrate both clinical and laboratory data. Slide agglutination method Examine microscopically the presence or absence of clumps within 1 minute after removing the slide from the rotator comparing the test results with the control sera. The reactions obtained in the slide titration method, are roughly equivalent to those which would occur in tube test with serum dilutions of 1/20, 1/40, 1/80, 1/160 and 1/320 respectively. If a reaction is found it is advisable to confirm the reaction and establish the titer by a tube test. (*) also useful for Brucella suis antibodies Tube agglutination test REAGENTS COMPOSITION There is not any international Reference for the sensitivity standardization of these reagents. For this reason, an internal control is used that contains animal serum with antibodies anti-Salmonellas, Brucellas and Proteus, and tittered with commercial reagents of certified quality. Examine microscopically the pattern of agglutination and compare the results with those given by all control tubes. A somatic reaction (O) is characterized by coarse, compact agglutination, which tends to be difficult to disperse, while flagellar (H) has a characteristic loose, flocculant agglutination. Positive control should give partial or complete agglutination. Negative control should not give visible clumping. Partial or complete clumping with variable degree of clearing of the supernatant fluid should be recorded as a positive result. The titer is the highest dilution that shows positive result. STORAGE AND STABILITY QUALITY CONTROL The reagents and controls are stable up to the expiry date when stored at +2 to 8°C. Do not freeze ! The controls and reagents are ready to use. The reagent tends to settle down. Shake the Reagent before use. After that it must be uniform and without visible clumping. The presence of particles and clumps are signs of deterioration. Positive and Negative controls are recommended to monitor the performance of the procedure, as well as a comparative pattern for a better result interpretation. - Bacterial Antigens: Suspensions of Salmonellas, Brucellas and Proteus in glycine buffer, pH 8.2. Sodium azida 0.95 g/L. - Controls: Animal serum. Sodium azide 0.95 g/L. CALIBRATION ADDITIONAL EQUIPMENT - Mechanical rotator adjustable to 80 -100 rpm - Incubator at 37°C SAMPLES Use fresh serum obtained by centrifugation of clotted blood. The sample may be stored 8 days at 2°-8°C or 3 months -20°C. Highly hemolyzed or lipemic samples must be discarded. The samples with presence of fibrin should be centrifuged before testing. PROCEDURE A. Slide agglutination (qualitative) 1. Bring reagents and specimens to room temperature before use. 2. Gently shake the reagent to disperse the particles until you get a homogeneous mixture. 3. Place 50 µlnote 1-2 of undiluted serum and 1 drop of Positive and Negative controls onto separate circles of the slide. 4. Add a drop (50 µl) of the Reagent next to the drop of serum. 5. Mix both drops spreading them over the full surface of the circle 6. Rotate the slide manually or with mechanical shaker (80 - 100 rpm) during 1 minute. B. Slide agglutination (titration) 1. Using a micropipette, deliver 80, 40, 20, 10 and 5 µL of undiluted serum into separate circles of the slide test. 2. Place a drop (50 µl) of the Reagent next to the serum. 3. Mix both drops spreading them over the full surface of the circle 4. Rotate the slide manually or with mechanical shaker (80 - 100 rpm) during 1 minute. REFERENCE RANGES Salmonellas: Titers ≥ 1/80 (O antibodies) and ≥ 1/160 (H antibodies) indicates recent infection. Brucellas: Titers ≥ 1/80 indicate infection. Proteus: Titers OX19 ≥ 1/80, OX2 ≥ 1/20 and OXK ≥ 1/80 indicate infection. The level of “normal” agglutinins to these organisms varies in different countries and different communities. It is recommended that each laboratory establish its own reference range. INTERFERENCES Bilirubin (20 mg/dL), hemoglobin (10 g/L), lipids (10 g/L) and rheumatoid factors (300 IU/mL), do not interfere. LIMITATIONS OF PROCEDURE - False negative results can be obtained in early disease, immuneunresponsiveness, prozone (Brucelosis), and antibiotic treatment. (somatic). - Serological cross-reactions with Brucella have been reported in cases of infection/vaccination with some strains of Vibrio cholerae, Pasteurella, Proteus OX19 and Y. enterocolitica (serotype 9). - A great number of false positive reactions have been reported in healthy individuals with Proteus antigens, especially in slide agglutination test. A titer of less than 1/160 should not be considered significant. NOTES 1. When testing for Brucella antibodies it is recommended to reduce sample volume to 20 µl to avoid prozone 2. In some geographical areas with a high prevalence of febrile antibodies, it is recommended to dilute samples 1/4 in saline before to perform the assay. BIBLIOGRAPHY 1. Edward J Young. Clinical Infectious diseases 1995; 21: 283-290 2. Coulter JBS. Current Pediatrics 1996; 6: 25-29. 3. David Aet al. Current Opinion in Infectious Diseases 1994; 7: 616-623. 4. David Aet al. Current Opinion in Infectious Diseases 1993; 6: 54-62. 5. Bradley D Jones. Annu Rev Immunol 1996; 14: 533-561. Langdorp, 03.2010 www.diagnostics.be Langdorpsesteenweg 160 • 3201 Langdorp • Belgium • Tel: ++ 32 16 44 63 89 • Fax: ++ 32 16 44 77 62 • e-mail: [email protected]